WallStreetZenWallStreetZen

NASDAQ: VRPX
Virpax Pharmaceuticals Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

VRPX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$18.0M
Current Profit Margin
0%

VRPX Return on Equity

Current Company
-92.3%
Current Industry
-17.9%
Current Market
30.8%
VRPX's Return on Equity (-92.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VRPX announces earnings.

VRPX Return on Assets

Current Company
-79.1%
Current Industry
1%
VRPX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VRPX Return on Capital Employed

Current Company
-118.65%
Current Industry
14.2%

VRPX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VRPX$0.00-$18.03M-$18.03MN/AN/A
PALI$250.00k-$12.24M-$12.40M-0.78%N/A
ENVB$0.00-$19.66M-$19.08M-100.00%N/A
CYCN$914.00k-$38.41M-$38.05M-94.15%N/A
PTIX$0.00-$2.78M-$2.91MN/AN/A
View Top Biotech Stocks

Virpax Pharmaceuticals Earnings & Revenue FAQ

What were VRPX's earnings last quarter?

On Invalid Date, Virpax Pharmaceuticals (NASDAQ: VRPX) reported Q1 2023 earnings per share (EPS) of -$0.13, up 70.45% year over year. Total Virpax Pharmaceuticals earnings for the quarter were -$1.52 million. In the same quarter last year, Virpax Pharmaceuticals's earnings per share (EPS) was -$0.44.

If you're new to stock investing, here's how to buy Virpax Pharmaceuticals stock.

What was VRPX's earnings growth in the past year?

As of Q2 2023, Virpax Pharmaceuticals's earnings has grown year over year. Virpax Pharmaceuticals's earnings in the past year totalled -$18.03 million.

What was VRPX's revenue last quarter?

On Invalid Date, Virpax Pharmaceuticals (NASDAQ: VRPX) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Virpax Pharmaceuticals's revenue was $0.00.

What was VRPX's revenue growth in the past year?

As of Q2 2023, Virpax Pharmaceuticals's revenue has grown null year over year. Virpax Pharmaceuticals's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.